Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT.
- DOI
- 10.1186/s40164-026-00827-8
- Published
- 2026 Sep 19
- Container
- Experimental hematology & oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40164-026-00827-8,
title = {Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT.},
author = {Ye Y and Galimard JE and Labopin M and Ayuk F and Yakoub-Agha I and Stelljes M and Salmenniemi U and Schroeder T and Bug G and Gallego-Hernanz MP and Forcade E and Passweg J and Itala-Remes M and Piemontese S and Sanz J and Bazarbachi A and Nagler A and Brissot E and Li L and Luo Y and Shi J and Zhao Y and Mohty M and Huang H and Ciceri F and Gorin NC},
year = {2026},
journal = {Experimental hematology \& oncology},
doi = {10.1186/s40164-026-00827-8},
url = {https://doi.org/10.1186/s40164-026-00827-8}
}RIS
TY - JOUR TI - Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT. AU - Ye Y AU - Galimard JE AU - Labopin M AU - Ayuk F AU - Yakoub-Agha I AU - Stelljes M AU - Salmenniemi U AU - Schroeder T AU - Bug G AU - Gallego-Hernanz MP AU - Forcade E AU - Passweg J AU - Itala-Remes M AU - Piemontese S AU - Sanz J AU - Bazarbachi A AU - Nagler A AU - Brissot E AU - Li L AU - Luo Y AU - Shi J AU - Zhao Y AU - Mohty M AU - Huang H AU - Ciceri F AU - Gorin NC PY - 2026 JO - Experimental hematology & oncology DO - 10.1186/s40164-026-00827-8 UR - https://doi.org/10.1186/s40164-026-00827-8 ER -
APA
Y, Y., JE, G., M, L., F, A., I, Y., M, S., U, S., T, S., G, B., MP, G., E, F., J, P., M, I., S, P., J, S., A, B., A, N., E, B., L, L., Y, L., J, S., Y, Z., M, M., H, H., F, C., & NC, G. (2026). Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT.. Experimental hematology & oncology. https://doi.org/10.1186/s40164-026-00827-8
Source records
- pubmed · retrieved 2026-09-26T00:54:26.640Z
- europe-pmc · retrieved 2026-09-26T00:54:26.652Z
- doaj · retrieved 2026-09-26T00:54:26.670Z